PROCEPT BioRobotics Corporation Common Stock (PRCT) — Analysis Summary
PROCEPT BioRobotics Corporation Common Stock (PRCT) has a market cap of $1.32B with year-over-year revenue growth of +37.2%. Net margin stands at -31.0%. The stock trades at a P/E ratio of -12.9.
Key Takeaways
- Revenue changed +37.2% year-over-year
- Net margin of -31.0%
- P/E ratio of -12.9
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, PRCT posted revenue growth of +37.2% and trades at a P/E of -12.9.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.